title: Effect of insulin-like growth factor-I therapy on erythropoetin concentrations in extreme insulin resistance.
authors.forename: J D
authors.initials: JD
authors.lastname: Quin
authors.forename: J P
authors.initials: JP
authors.lastname: Miell
authors.forename: K
authors.initials: K
authors.lastname: Smith
authors.forename: D
authors.initials: D
authors.lastname: Gordon
authors.forename: J
authors.initials: J
authors.lastname: Strachan
authors.forename: J B
authors.initials: JB
authors.lastname: Dick
authors.forename: A C
authors.initials: AC
authors.lastname: MacCuish
mesh_terms: D000293:Adolescent; D004921:Erythropoietin / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin; D007334:Insulin-Like Growth Factor I